Therapeutic mechanistic study of novel indole derivatives as SIRTUIN3 modulators in Parkinson’s disease with in vitro evaluation

Abstract SIRT3 modulates reactive oxygen species and helps to reduce oxidative stress, resulting in a neuroprotective effect in Parkinson’s disease. The work seeks to develop and synthesize novel, effective SIRT3 modulators, which will modify SIRT3 expression and generate the neuroprotective effect...

Full description

Saved in:
Bibliographic Details
Main Authors: Jagdish Chand, Srikanth Jupudi, Sheikh F. Ahmad, Talha Bin Emran, Gomathy Subramanian
Format: Article
Language:English
Published: Nature Portfolio 2025-04-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-99534-3
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850206083557097472
author Jagdish Chand
Srikanth Jupudi
Sheikh F. Ahmad
Talha Bin Emran
Gomathy Subramanian
author_facet Jagdish Chand
Srikanth Jupudi
Sheikh F. Ahmad
Talha Bin Emran
Gomathy Subramanian
author_sort Jagdish Chand
collection DOAJ
description Abstract SIRT3 modulates reactive oxygen species and helps to reduce oxidative stress, resulting in a neuroprotective effect in Parkinson’s disease. The work seeks to develop and synthesize novel, effective SIRT3 modulators, which will modify SIRT3 expression and generate the neuroprotective effect by downregulating reactive oxygen species. The synthesis of the new indole-based carboxamide derivatives IMW 1–16 was guided by molecular docking experiments with the SIRT3 wild-type protein. FT-IR, 1H-NMR, 13C-NMR, and mass spectrometry analyzed the synthesized compounds. The efficacy of the compounds IMW 1–16 was assessed using in-vitro assays such as the MTT assay, neuroprotection assay, lactate dehydrogenase assay, superoxide dismutase assay, glutathione peroxidase assay, reactive oxygen species estimation, mitochondrial membrane potential, and real-time polymerase chain reaction estimation. The synthesized compounds IMFW-1, IMTW-5, and IM24DCW-16 were determined to have the lowest cytotoxicity and the most neuroprotective effect. They were found to downregulate the lactate dehydrogenase enzyme levels. The compounds efficiently increased the expression of superoxide dismutase and glutathione peroxidase. They were shown to be beneficial in reducing reactive oxygen species levels. The compounds also significantly increased the expression of SIRT3, PGC-1α, and FOXO3, which are crucial for detoxifying reactive oxygen species. The synthesized novel indole-based carboxamide derivatives were effective modulators of SIRT3. Upregulating SIRT3 expression also upregulated other supporting proteins such as PGC-1α, SOD2, GPx, and FOXO3, and these targets have been known to downregulate the reactive oxygen species levels. The study’s findings reveal the therapeutic potential of the developed and synthesized compounds and their involvement in such pathological situations; among all the compounds, IM24DCW-16 was discovered to be the most promising candidate for the modulation of the SIRT3 in PD.
format Article
id doaj-art-2c3d1ca429dc4eadaa908cabbd383cd6
institution OA Journals
issn 2045-2322
language English
publishDate 2025-04-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-2c3d1ca429dc4eadaa908cabbd383cd62025-08-20T02:10:56ZengNature PortfolioScientific Reports2045-23222025-04-0115112210.1038/s41598-025-99534-3Therapeutic mechanistic study of novel indole derivatives as SIRTUIN3 modulators in Parkinson’s disease with in vitro evaluationJagdish Chand0Srikanth Jupudi1Sheikh F. Ahmad2Talha Bin Emran3Gomathy Subramanian4Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education & Research, OotyDepartment of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education & Research, OotyDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud UniversityDepartment of Pathology and Laboratory Medicine, Warren Alpert Medical School, Brown UniversityDepartment of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education & Research, OotyAbstract SIRT3 modulates reactive oxygen species and helps to reduce oxidative stress, resulting in a neuroprotective effect in Parkinson’s disease. The work seeks to develop and synthesize novel, effective SIRT3 modulators, which will modify SIRT3 expression and generate the neuroprotective effect by downregulating reactive oxygen species. The synthesis of the new indole-based carboxamide derivatives IMW 1–16 was guided by molecular docking experiments with the SIRT3 wild-type protein. FT-IR, 1H-NMR, 13C-NMR, and mass spectrometry analyzed the synthesized compounds. The efficacy of the compounds IMW 1–16 was assessed using in-vitro assays such as the MTT assay, neuroprotection assay, lactate dehydrogenase assay, superoxide dismutase assay, glutathione peroxidase assay, reactive oxygen species estimation, mitochondrial membrane potential, and real-time polymerase chain reaction estimation. The synthesized compounds IMFW-1, IMTW-5, and IM24DCW-16 were determined to have the lowest cytotoxicity and the most neuroprotective effect. They were found to downregulate the lactate dehydrogenase enzyme levels. The compounds efficiently increased the expression of superoxide dismutase and glutathione peroxidase. They were shown to be beneficial in reducing reactive oxygen species levels. The compounds also significantly increased the expression of SIRT3, PGC-1α, and FOXO3, which are crucial for detoxifying reactive oxygen species. The synthesized novel indole-based carboxamide derivatives were effective modulators of SIRT3. Upregulating SIRT3 expression also upregulated other supporting proteins such as PGC-1α, SOD2, GPx, and FOXO3, and these targets have been known to downregulate the reactive oxygen species levels. The study’s findings reveal the therapeutic potential of the developed and synthesized compounds and their involvement in such pathological situations; among all the compounds, IM24DCW-16 was discovered to be the most promising candidate for the modulation of the SIRT3 in PD.https://doi.org/10.1038/s41598-025-99534-3Molecular dockingIndole derivativesParkinson’s diseaseSIRT3SHSY-5Y neuroblastoma cell lines
spellingShingle Jagdish Chand
Srikanth Jupudi
Sheikh F. Ahmad
Talha Bin Emran
Gomathy Subramanian
Therapeutic mechanistic study of novel indole derivatives as SIRTUIN3 modulators in Parkinson’s disease with in vitro evaluation
Scientific Reports
Molecular docking
Indole derivatives
Parkinson’s disease
SIRT3
SHSY-5Y neuroblastoma cell lines
title Therapeutic mechanistic study of novel indole derivatives as SIRTUIN3 modulators in Parkinson’s disease with in vitro evaluation
title_full Therapeutic mechanistic study of novel indole derivatives as SIRTUIN3 modulators in Parkinson’s disease with in vitro evaluation
title_fullStr Therapeutic mechanistic study of novel indole derivatives as SIRTUIN3 modulators in Parkinson’s disease with in vitro evaluation
title_full_unstemmed Therapeutic mechanistic study of novel indole derivatives as SIRTUIN3 modulators in Parkinson’s disease with in vitro evaluation
title_short Therapeutic mechanistic study of novel indole derivatives as SIRTUIN3 modulators in Parkinson’s disease with in vitro evaluation
title_sort therapeutic mechanistic study of novel indole derivatives as sirtuin3 modulators in parkinson s disease with in vitro evaluation
topic Molecular docking
Indole derivatives
Parkinson’s disease
SIRT3
SHSY-5Y neuroblastoma cell lines
url https://doi.org/10.1038/s41598-025-99534-3
work_keys_str_mv AT jagdishchand therapeuticmechanisticstudyofnovelindolederivativesassirtuin3modulatorsinparkinsonsdiseasewithinvitroevaluation
AT srikanthjupudi therapeuticmechanisticstudyofnovelindolederivativesassirtuin3modulatorsinparkinsonsdiseasewithinvitroevaluation
AT sheikhfahmad therapeuticmechanisticstudyofnovelindolederivativesassirtuin3modulatorsinparkinsonsdiseasewithinvitroevaluation
AT talhabinemran therapeuticmechanisticstudyofnovelindolederivativesassirtuin3modulatorsinparkinsonsdiseasewithinvitroevaluation
AT gomathysubramanian therapeuticmechanisticstudyofnovelindolederivativesassirtuin3modulatorsinparkinsonsdiseasewithinvitroevaluation